Andrew J. Deans is a haematologist-oncologist based in Fitzroy, VIC, Australia. He looks after people who have conditions that affect the blood, the bone marrow, or both. This can include serious blood disorders that show up in childhood, as well as some long-term conditions that start from birth.
In everyday terms, Andrew’s work often involves helping patients and families through times that can feel confusing and scary. Blood health is a big deal for your whole body, so even when symptoms seem small at first, they can quickly become something that needs close care. At times, treatment plans can be complex, and that’s why clear communication matters from the start.
His clinical focus includes congenital anaemias and aplastic anaemia, including congenital aplastic anaemia and Fanconi anaemia. He also supports people who have other inherited bone marrow and DNA repair conditions, where the body’s ability to make healthy blood cells is affected. Over time, patients may need careful monitoring, supportive care, and treatment decisions that take the bigger picture into account.
Andrew also works with childhood cancers and related blood conditions. This can include childhood acute myeloid leukaemia. In some cases, eye cancer like retinoblastoma is part of the care pathway, often alongside other health needs. Childhood cases can move fast, so having a doctor who’s used to coordinating care and staying on top of changes is important.
Because these conditions are often rare, families may feel like they’re learning new terms every day. Andrew’s approach is to keep things grounded. He explains what is happening in plain language, talks through options, and helps families understand what to watch for between appointments. It’s not about making big promises. It’s about making a plan that fits the patient’s situation.
Andrew’s medical training includes time in both haematology and oncology, so he understands the overlap between blood disorders and cancer care. He also works with the team around each patient, which can involve other specialists and support services, depending on the case.
Research and clinical trials can be relevant for some patients in this space, especially where conditions are rare or long-term. If a trial is an option, it’s usually discussed as part of the overall care plan, along with the expected benefits and the things to consider. In short, Andrew helps people weigh up decisions carefully, with support throughout.